NCT03070964 2020-10-14
A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma
PharmaMar
Phase 2 Terminated
Clinical Trials
3 trialsNCT00884286 2018-04-25
Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma
PharmaMar
Phase 2 Completed
NCT00788099 2011-06-07
Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas
PharmaMar
Phase 1 Completed